A protein peptide with antibacterial activity and its application in preparing biofilm
By extracting and enzymatically decomposed scallop foot peptides with antibacterial activity from scallop foot silk, and coupling them to the polypeptide, a broad-spectrum antibacterial biofilm was prepared, which solved the problem of limited resistance and bactericidal effect of traditional antibiotics, and achieved the goal of achieving An economical and effective solution to effective inhibition of drug-resistant E. coli and wound healing.
Patent Information
- Application Number
- CN202410553436.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-07
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-05-07
AI Technical Summary
Existing antibiotics are prone to drug resistance and have limited bactericidal effects on a variety of microorganisms, making it difficult to effectively solve complex infection and healing problems.
Biofilm with broad-spectrum antibacterial effect was prepared by extracting and enzymatically decomposed from scalloped foot silk and coupling it to polypeptides with film-forming properties, and biofilm with broad-spectrum antibacterial effects was prepared for skin infections and wounds. heal.
This method effectively inhibits drug-resistant E. coli, providing an economical and widely used alternative, with good antibacterial properties and healing effects, and avoids the drug resistance of traditional antibiotics.
Smart Images

Figure CN118359678B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of active peptide screening and application, and in particular relates to a protein peptide with antibacterial activity and application thereof in preparing biofilm. Background Art
[0002] Antimicrobial peptides are a class of small molecule polypeptides with antimicrobial activity that are widely present in organisms and are part of the biological system's defense. They have a small molecular weight, and most of them have 12 to 100 amino acid residues; they are thermally stable, and most of them still maintain a certain activity after being heated at 100°C for 10 minutes; they have a wide antimicrobial spectrum, not only killing bacteria, fungi, viruses, mycoplasmas, spirochetes and some active cells, but also playing an important role in immune regulation, hormone regulation and stimulating wound healing; they have a unique mechanism of action, and antimicrobial peptides are different from traditional antibiotics such as penicillin, and their unique mechanism of action basically does not produce drug resistance.
[0003] Since the 1980s, when Swedish scientists isolated the world's first antimicrobial peptide, Cecropins, from the diapause pupae of Cecropinus cecropia, researchers have discovered and isolated a large number of antimicrobial peptides from amphibians, insects, plants, mammals, microorganisms and even humans themselves. Now, it is shown that more than 3,000 antimicrobial peptides have been isolated and identified, and included in the Antimicrobial Peptide Database (AFD) established by the Nebraska Medical Center in the United States, and the number is still increasing at a high level every year. Antimicrobial peptides have multiple biological activities, wide functions, broad-spectrum bactericidal effects, and due to their natural antibacterial properties and low bacterial resistance, they have become a good substitute for antibiotics and other antimicrobial drugs, and have broad development and application prospects. Summary of the invention
[0004] The purpose of the present invention is to provide a protein peptide with antibacterial activity and its application in preparing biofilm. The provided protein peptide is used to prepare biofilm with antibacterial efficacy.
[0005] The present invention first provides a scallop byssus peptide with antibacterial activity. The preparation method of the scallop byssus peptide comprises the following steps: adding water to scallop byssus minced meat to prepare a homogenate, then adding protease to perform enzymolysis, and concentrating and drying the enzymolysis solution to prepare the scallop byssus peptide with antibacterial activity;
[0006] The process conditions for enzymatic hydrolysis of scallop byssus peptide provided by the present invention are pH 8, substrate concentration 5%, and reaction temperature 40°C;
[0007] Furthermore, the protease is a neutral protease;
[0008] Furthermore, the scallop byssus antimicrobial peptide has an amino acid sequence of IFDPGDLDPD (SEQ ID NO: 1) and EIQFGTDGPLFG (SEQ ID NO: 2);
[0009] Furthermore, the amino acid sequence of the antimicrobial peptide is FGTFDPLFDPDGTILQ (SEQ ID NO: 3);
[0010] The antimicrobial peptide provided by the present invention is used to prepare biofilm;
[0011] In another aspect, the present invention further provides a biofilm, which is prepared by coupling the scallop byssus antimicrobial peptide with a polypeptide having film-forming properties;
[0012] The polypeptide having film-forming properties has an amino acid sequence as follows:
[0013] DECTSKGQCTALDGVTCVSLGQQRLEKCNTYTCRRSNNVLKYK
[0014] IVKNLLKCKRPDGTSMDIGVGEKDETKCTTEICRRARNSDGTFTLTY
[0015] REKPYGCPLTDGSCLLFGKRNKIRNENKCLDTTCTRRKNKKGQYISR
[0016] LKNKYYGCPNNGVCEDAEATRNNSCTSYMCVLSKRRTLMKWEILKT
[0017] GCKTDEGCKYDTDEWTDPDASSCVTRRCDVTFNPTDKTYNSVNRVA
[0018] RHGCRASNGTCYYNSETWLENDCYTRRCDVTTTTDKGESMAAIKIES
[0019] GICKDADGSCKGYGEAMQYRSGAATLNCVCDEAISTQGYPQGRPVC
[0020] KSP (SEQ ID NO: 4).
[0021] The polypeptide provided by the present invention has good antibacterial properties, and one of the antibacterial peptides has a better antibacterial effect on drug-resistant Escherichia coli. The polypeptide prepared by the present invention can be used to prepare biofilms, applied to skin infections, wound treatment and wound healing, and has good economic and application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 : Histogram of hydrolysis rate of scallop byssus by different proteases;
[0023] Figure 2 : Line graph showing the effect of temperature on hydrolysis rate;
[0024] Figure 3 :Line graph showing the effect of pH value on hydrolysis rate;
[0025] Figure 4 : Line graph showing the effect of enzyme and substrate concentration on hydrolysis rate;
[0026] Figure 5 : Line graph showing the influence of hydrolysis time and hydrolysis rate;
[0027] Figure 6 : Line graph showing the effect of substrate concentration on hydrolysis rate;
[0028] Figure 7 : Antibacterial performance of scallop byssus peptide;
[0029] Figure 8 :Peptide HPLC spectrum;
[0030] Fig. 9 : Detection diagram of the purified product. DETAILED DESCRIPTION
[0031] The present invention is described in detail below in conjunction with specific embodiments and drawings.
[0032] Example 1: Preparation of scallop byssin peptide with antibacterial properties
[0033] 1. Select the enzyme with the best hydrolysis effect on scallop byssus
[0034] Six proteases were selected: neutral protease, alkaline protease, papain, pepsin, trypsin and flavor protease for hydrolysis test of scallop byssus. The hydrolysis rate was used as the test index for screening. The three conditions of substrate concentration, enzyme-substrate concentration ratio and reaction time were set consistently in each experiment.
[0035] The hydrolysis process is as follows:
[0036] 4% concentration of scallop byssuspension → adjust pH value according to the characteristics of each protease → add a certain amount of protease → constant temperature enzymolysis according to the suitable temperature of different proteases → 100℃, 10min enzyme inactivation → 8000r / min centrifugation for 15min → take the supernatant to determine the hydrolysis rate.
[0037] The enzymatic hydrolysis conditions are shown in Table 1.
[0038] Table 1: Enzymatic hydrolysis conditions of various enzymes
[0039]
[0040] Depend on Figure 1 As shown, among the six selected proteases, the neutral protease had the highest hydrolysis rate. Therefore, the neutral protease was selected as the experimental enzyme, and the five single factor conditions affecting the activity of the neutral protease were optimized.
[0041] 2. Optimization of enzymatic hydrolysis conditions
[0042] The optimization test of neutral protease hydrolysis examined five single-factor experimental conditions: temperature, pH value, enzyme-substrate concentration ratio, hydrolysis time, and substrate concentration (S%). According to the characteristics of the selected enzyme, the basic conditions were selected as follows: reaction temperature 50°C, pH value 7, enzyme-substrate concentration ratio 9%, reaction time 4h, and substrate concentration (s%) 4%. Gradients of each single factor: reaction temperature: 30°C, 40°C, 50°C, 60°C, 70°C. pH value: 5, 6, 7, 8, 9. Enzyme-substrate concentration ratio: 5%, 7%, 9%, 11%, 13%. Reaction time: 2h, 3h, 4h, 5h, 6h. Substrate concentration (s%): 2%, 3%, 4%, 5%, 6%.
[0043] (1) Effect of temperature on hydrolysis rate
[0044] A single factor test was conducted with a substrate concentration of 4%, an enzyme to substrate concentration ratio of 9%, a pH value of 7, a reaction time of 6 h, and temperatures of 30°C, 40°C, 50°C, 60°C, and 70°C.
[0045] Depend on Figure 2 It can be seen that at 30-50℃, as the temperature increases, the enzymatic reaction is accelerated and the hydrolysis rate increases accordingly. However, as the temperature continues to rise, the protease gradually denatures and inactivates under the influence of high temperature, and the hydrolysis rate shows a downward trend. Therefore, it is more appropriate to choose a temperature of 50℃.
[0046] (2) Relationship between pH value and hydrolysis rate
[0047] A single factor test was conducted with a substrate concentration of 4%, an enzyme to substrate concentration ratio of 9%, a temperature of 50°C, a reaction time of 6h, and pH values of 5, 6, 7, 8, and 9.
[0048] Depend on Figure 3 It can be seen that when the pH is less than 7, the pH has little effect on promoting the hydrolysis of proteases. When the pH value rises to 8, the hydrolysis rate is the highest, so a pH value of 8 is more appropriate.
[0049] (3) Relationship between enzyme-substrate concentration ratio and hydrolysis rate
[0050] A single factor test was conducted with a substrate concentration of 4%, a pH value of 8, a temperature of 50°C, a reaction time of 6 h, and an enzyme to substrate concentration ratio of 5%, 7%, 9%, 11%, and 13%.
[0051] Depend on Figure 4 It can be seen that with the increase of the enzyme-substrate concentration ratio, the binding efficiency of the enzyme and the substrate is greatly improved. However, when the enzyme amount increases to a certain value, the enzyme molecules tend to be saturated and the hydrolysis rate has no obvious upward trend. The enzyme-substrate concentration ratio is selected to be 11%.
[0052] (4) Relationship between enzymatic hydrolysis time and hydrolysis rate
[0053] A single factor test was conducted with a substrate concentration of 4%, a pH value of 8, a temperature of 50°C, an enzyme to substrate concentration ratio of 11%, and reaction times of 2h, 3h, 4h, 5h, 6h, 7h, and 8h.
[0054] Depend on Figure 5 It can be seen that in the early stage of the enzymatic reaction, as the enzymatic time increases, the hydrolysis rate continues to increase, indicating that the substrate scallop byssus has not been completely enzymatically hydrolyzed by the neutral protease during this period. After the enzymatic time reaches 4h, the hydrolysis rate slows down with the increase of enzymatic time, indicating that the scallop byssus has basically been completely enzymatically hydrolyzed at this time, and the extension of enzymatic time has no particularly large impact on the enzymatic effect. Considering the aspects of saving resources and energy and improving production efficiency, the enzymatic time is selected to be 4h.
[0055] (5) Relationship between substrate concentration and hydrolysis rate
[0056] The enzymatic reaction pH value was selected as 8, the temperature was 50°C, the enzyme to substrate concentration ratio was 11%, the reaction time was 4h, and the substrate concentrations were 2%, 3%, 4%, 5%, 6%, 7%, and 8% for a single factor experiment.
[0057] Depend on Figure 6 It can be seen that the hydrolysis rate is the highest when the substrate concentration is 4%. At higher substrate concentrations, the enzyme and substrate cannot be fully hydrolyzed because the binding is not saturated, so the substrate concentration is selected to be 4%.
[0058] (6) Orthogonal test
[0059] According to the single factor test and related literature, the enzymatic hydrolysis time has little effect on the hydrolysis, and the hydrolysis time can be selected as 4h. The other four factors are used to design the orthogonal test: pH values are selected as 7, 8, and 9, substrate concentrations are 3%, 4%, and 5%, and reaction temperatures are 40, 50, and 60°C. The enzyme-substrate concentration ratio is 9%, 11%, and 13%, and the dps software is used to conduct a four-factor three-level orthogonal test. L9(3 4 ) is designed as shown in Table 2.
[0060] Table 2: Orthogonal test level factor table
[0061]
[0062]
[0063] Table 3: Orthogonal test results and range analysis table of optimized level conditions
[0064]
[0065] As shown in Table 3, each test was conducted in three parallels, namely DH1, DH2, and DH3, and the range analysis was performed. The ranges of factors A, B, C, and D were 1.687, 3.172, 4.378, and 3.451, respectively. The larger the range, the greater the degree to which this factor affects the hydrolysis rate. Therefore, the order of the influence of each factor on the hydrolysis rate is C>D>B>A, that is, temperature>enzyme to substrate concentration ratio>substrate concentration>pH.
[0066] Table 4: Significant difference test among treatments
[0067]
[0068]
[0069] As shown in Table 4, the optimal enzymatic hydrolysis process of scallop byssus silk obtained from the orthogonal test results is pH 8, substrate concentration of 5%, reaction temperature of 40°C, and enzyme to substrate concentration ratio of 11%. Under this optimal condition, the hydrolysis rate is the highest, which is 26.96%.
[0070] Example 2: Detection of antibacterial effect of scallop byssin peptide
[0071] The enzymatic hydrolysate was centrifuged at 12000r / min for 20min at 4°C. The enzymatic hydrolysate supernatant obtained by centrifugation was taken out and filtered with a 0.45μm filter membrane to remove impurities such as unhydrolyzed skirts and macromolecular proteins. The filtrate was ultrafiltered using an ultrafiltration device to separate the enzymatic hydrolysate. The ultrafiltration conditions were: maintaining the inlet pressure Pin = 103-138kPa, the outlet pressure Pout = 0-34kPa, and the pressure difference was constant at 103kPa.
[0072] The filter membranes used were 1 kDa, 3 kDa and 5 kDa. The permeate and the retentate were concentrated by rotary evaporation, solidified at -18°C and then freeze-dried.
[0073] The antibacterial effect of the four separated components was determined by the cup-plate method. Specifically, the test strain was inoculated into MH liquid culture medium, cultured at 37°C until the logarithmic growth phase, and the bacterial solution was diluted to 10 by McFarland turbidimetry. 7cfu / mL. After mixing with an oscillator, 0.1 mL of the diluted bacterial solution was spread on the MH solid medium in the culture dish. Four sterilized Oxford cups [inner diameter (6.0±0.1) mm, outer diameter (7.8±0.1) mm, height (10.0±0.1) mm] were placed symmetrically in the culture dish, and the corresponding positions of each Oxford cup were marked. 0.1 g of different components were dissolved in 10 mL of sterile water and diluted. 0.1 mL of the dilution was aseptically added to the Oxford cup, and placed in a 37°C constant temperature incubator for 24 hours to observe the inhibition zone, and the diameter of the inhibition zone in the plate was measured. Repeat 3 times and calculate the average value.
[0074] The four separated components were quantitatively diluted respectively, and the antibacterial effect of the antimicrobial peptides was observed by the cup-disc method.
[0075] The results show that ( Figure 7 ) The antimicrobial peptides produced by the neutral protease hydrolysis of scallop byssus that inhibit Escherichia coli are mainly distributed in the 1-3kDa component and the <1kDa component hydrolyzate, and the 3-5kDa and >5kDa component hydrolyzates have no obvious antibacterial activity. Through measurement, it can be seen that the diameter of the 1-3kDa inhibition zone is 10.8mm, and the diameter of the <1kDa inhibition zone is 9.9mm. The results show that the 1-3kDa component hydrolyzate has better antibacterial activity.
[0076] The minimum inhibitory concentration (MIC) of the 1-3 kDa component hydrolysate was determined by the microdilution method. The separated 1-3 kDa component hydrolysate was dissolved in sterile water and then diluted with MH medium. The dilution was a gradient dilution centered at 10 μg / mL, and the final concentrations were 160, 80, 40, 20, 10, 5, 2.5, 1.25, and 0.625 μg / mL, respectively. 100 μL of each was added to a polystyrene U-shaped microplate. Two standard bacteria cultured in MH medium in the logarithmic growth phase were diluted to 10 with sterile water. 7 cfu / mL as the inoculation solution. Add 5 μL to each well, and the final inoculation volume per well is 10 4 cfu. A blank control well was set on each plate without adding antimicrobial peptide. The results were observed after incubation at 36°C in a biochemical incubator for 12 to 18 hours.
[0077] Table 5: MIC values of 1-3 kDa component hydrolysate for test bacteria (μg / mL)
[0078]
[0079] The minimum inhibitory concentration (MIC) of the antimicrobial peptides was determined by microdilution method. As shown in Table 5, the MIC values of the neutral protease scallop byssus hydrolyzate (1 kDa-3 kDa) against Escherichia coli and Staphylococcus aureus were both 40 μg / mL.
[0080] Example 3: Peptide purification and sequence determination
[0081] 1. Purification of peptides
[0082] 1 mL of 1-3 kDa component hydrolyzate was placed in ultrapure water containing 0.1% trifluoroacetic acid (TFA) and filtered using a 0.22 μm filter membrane. Mobile phase A was 0.1% TFA-H 2 0, mobile phase B was 0.1% TFA-acetonitrile (CH 3 CN), all elution solvents used must be filtered and ultrasonically treated to prevent bubbles from forming in the chromatographic column. After the baseline is stable, start loading the sample, and the loading volume is 10μL. The chromatographic column is a silica gel alkyl bonded phase C18 column (4.6mmidx250mm, particle size 5pmid, pore size 300 mesh). A binary mobile phase gradient elution system is used. Within 30 minutes, the content of mobile phase B in the eluent increases linearly from 0% to 100% (see Table 6). The system flow rate is 1mL / min, the detection wavelength is 215nm, and the detection is at room temperature.
[0083] The results are as follows Figure 8 As shown, after the polypeptide solution was purified by HPLC, a total of 7 elution peaks appeared. After microdilution method determination, the components of the third elution peak had obvious antibacterial effect. The purified product under the elution peak was collected, freeze-dried, and made into powder to obtain the purified polypeptide.
[0084] Table 6: HPLC gradient elution conditions
[0085]
[0086] 2. Determination of peptide sequence
[0087] The third elution peak component was purified by Pre-HPLC (methanol: water = 30:70, v / v) and silica gel column chromatography (dichloromethane: methanol = 43:1, v / v) to obtain a purified single peak ( Fig. 9 ) to achieve a purity that allows amino acid sequencing of the separated samples.
[0088] The purified peptides were sequenced and the chromatographic conditions were as follows: instrument type: LCM S-9030Q-TOF quadrupole-time-of-flight mass spectrometer, chromatographic column: Inertsil HILIC C18 reverse phase column 150 mm × 3.0 mm, 3 μm, Shimadzu, Japan), column temperature: 30 ° C, injection volume: 1.0 μL; mobile phase: A is 0.1% (v / v) formic acid aqueous solution, mobile phase B is 0.1% (v / v) formic acid acetonitrile solution, gradient elution program: 0-5.0 min, 5%, 5.0-10.0 min, 10%, 10.0 -15.0min, 20%, 15.0-20.0min, 40%; flow rate is 0.3mL / min, mass spectrometry ion mode: ESI source, positive ion mode, ion source interface voltage: 4.0kV, gas flow rate: 10.0L / min, drying gas flow rate: 10.0L / min, heating gas flow rate: 10.0L / min; heating module temperature: 400℃, interface temperature: 300℃, scanning mode: full scan mode (m / z50-2000).
[0089] The sequences of the purified and sequenced peptides are shown in Table 7, and the number of amino acids is between 9 and 13. The peptides in Table 7 were biosynthesized, and the minimum inhibitory concentration (MIC) of each peptide was determined. Among them, the antibacterial effects of the three peptides Sfs01 (SEQ ID NO: 1), Sfs02 (SEQ ID NO: 2), and Sfs03 (SEQ ID NO: 3) were significantly higher than those of the other peptides (Table 8).
[0090] Table 7: Scallop byssus peptide sequence list
[0091]
[0092] Table 8: Minimum inhibitory concentration of peptides against Escherichia coli (μg / mL)
[0093]
[0094]
[0095] During the experiment, it was found that the peptide FGTFDPLFDPDGTILQ (SEQ ID NO: 3) had a significant antibacterial effect on the drug-resistant Escherichia coli 577 (ATCC577, E. coli577). As shown in Table 9, the MIC of the polypeptide of SEQ ID NO: 3 against ATCC577 is much lower than that of the polypeptides of SEQ ID NO: 1 and SEQ ID NO: 2.
[0096] Table 9: Minimum inhibitory concentration (MIC) (μg / mL) of three antimicrobial peptides against ATCC577 strain
[0097]
[0098] Example 4 Preparation of antimicrobial peptide biofilm
[0099] The Sbp5-2-F peptide was coupled with the antimicrobial peptides Sfs01-Sfs03, and the coding genes of the coupled peptides were inserted into the vector pET32a to construct the recombinant expression vector Sbp-Sfs-pET32a. The recombinant vector was transformed into Escherichia coli DE3 competent cells, and the positive clones were selected and inoculated in 5 mL LB medium with kanamycin resistance. It was transferred as a mother liquid in LB medium with kanamycin resistance. When the bacterial concentration reached 10 7 cfu / mL, 0.2 mM IPTG was added for protein induction and incubated at 16°C for 22 hours. 1xPBS was added to the collected bacteria for suspension, and the bacteria were sonicated using an ultrasonic cell disruptor to purify the sufficiently expressed protein.
[0100] The recombinant expressed protein was purified to obtain protein lyophilized powder. The protein lyophilized powder was dissolved by adding hexafluoroisopropanol (HFIP) at a concentration of 60 mg / mL. 40 μL of the dissolved protein HFIP solution was added dropwise to a polytetrafluoroethylene circular mold with a diameter of 1 cm and a thickness of 1 mm. After standing for 2 minutes and HFIP was evaporated, PBS buffer was added dropwise to the surface of the membrane until the membrane was completely immersed in the liquid. After the membrane was allowed to stand in the buffer for 2 minutes, it could be removed with tweezers.
[0101] Add the E. coli culture solution to a glass test tube containing liquid culture medium and incubate it on a shaker at 37°C for 8 hours. Dilute the culture solution to 10 7 cfu / mL, the sterilized Sbp5-2-F protein membrane and Sbp-Sfs protein membrane were placed in the prepared bacterial suspension and mixed for 2 hours, then taken out and rinsed with sterile water for 3 times.
[0102] Add 1mL PBS to the centrifuge tube, then immerse the cleaned biofilm in it, and separate the bacteria on the membrane from the membrane by ultrasound. Take 50μL of PBS cleaning solution from the centrifuge tube and coat the plate and culture for 12 hours. Count the number of cells displayed on the plate. The blank group is the control group, and three parallel experiments are performed in each group. Calculate the anti-activity rate of the sample according to the following formula and estimate its anti-activity.
[0103] Antibacterial rate = (control group colonies - experimental group colonies) / control group colonies * 100%
[0104] Table 10: Antibacterial effect of protein film on Escherichia coli (%)
[0105]
[0106] In summary, the polypeptide solution obtained by hydrolysis of scallop byssus has good antibacterial properties, and the biofilm prepared by connecting it to a carrier protein also has a good antibacterial effect. The antimicrobial peptide prepared by the method of the present invention has good application prospects.
Claims
1. A scallop byssus peptide having antibacterial activity, characterized in that: The scallop byssus peptide is prepared by adding water to scallop byssus minced meat to prepare a homogenate, then adding protease for enzymolysis, and concentrating and drying the enzymolysis solution; the amino acid sequence of the scallop byssus peptide is SEQ ID NO:
1.
2. Use of the scallop byssin peptide according to claim 1 in the preparation of anti-Escherichia coli products.
3. The use according to claim 2, characterized in that The antibacterial product is a biofilm.
Citation Information
Patent Citations
Polypeptide with antibacterial effect
CN105367625A
Bionic functionalized protein-based membrane material and application thereof
CN114539427A
